Nephrology
Renal Colic
47
Pipeline Programs↗
9
Active Trials↗
17
Companies Involved↗
Renal Colic is a moderately active landscape with 47 programs across 17 companies. The most active players are Javelin Pharmaceuticals, Kenvue Brands, Roche. 16 therapies are approved with 10 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical10
Phase 28
Phase 310
Analysis
Trial Status
44
clinical trials
Completed25 · 57%
Unknown status6 · 14%
Not yet recruiting4 · 9%
Recruiting3 · 7%
Withdrawn3 · 7%
Active, not recruiting2 · 5%
Other1 · 2%
Clinical Trials
Trial Activity
44 trials
Analgesic Efficacy of Transcutaneous Electrical Nerve Stimulation and Dexketoprofen in Renal Colic
Not yet recruiting·—·Phase 4·NCT07176572·128 enrolled
Comparison of the Analgesic Efficacy of Dexketoprofen Trometamol, Meperidine, and Paracetamol in Renal Colic
Completed·—·Phase 4·NCT06558916·90 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)